Paradoxical Development of IgG4-Related Ophthalmic Disease During Dupilumab Therapy

Seminars in Ophthalmology 2026

View at publisher
Authors: Isana Nakajima, Ken Fukuda, Masato Okada, Kenji YAMASHIRO, Hideki Tsuji
DOI: 10.1080/08820538.2026.2614750
Cited by: 1
References: 15

Abstract

Dear Editor,Dupilumab, a human monoclonal antibody targeting the interleukin (IL)-4 receptor α-subunit, inhibits the signal transduction of IL-4 and IL-13. Dupilumab is therefore widely effective i...

Fields of Study & Subjects

IgG4-Related and Inflammatory Diseases Nasolacrimal Duct Obstruction Treatments Autoimmune Bullous Skin Diseases

Publication details

Journal / source
Seminars in Ophthalmology
Publisher
Informa UK Limited
Volume
41
Issue
4
Pages
547–549
Publication date
13 January 2026
Language
EN